N/A Completed N=60 Randomized Single-blind Treatment

Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial

Alcohol-Related Disorders · Liver disease

Source: ClinicalTrials.gov NCT04473482 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2023

Primary outcomePrimary: Feasibility of MAIN-ART Tool as Measured by Recruitment Rates — 60 Participants

Summary

The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their engagement with treatment and reduce alcohol use. This is an important area to study to help create ways to increase participants' knowledge about different treatment options as well as increase likelihood of seeking and participating in alcohol use disorder treatments.

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility of MAIN-ART Tool as Measured by Recruitment Rates	60	—
PRIMARY Feasibility of MAIN-ART Tool as Measured by Retention Rates	19; 19	—
PRIMARY Acceptability of the MAIN-ART Tool as Measured by Post-intervention Surveys	70	—
SECONDARY Alcohol Use Frequency as Measured by the Alcohol Timeline Follow-back (TLFB) Interview	87; 72; 13; 29	—
SECONDARY Alcohol Treatment Engagement as Measured by Number of Participants Who Engaged in Any Alcohol Cessation or Reduction Visit as Measured by Self-report.	8; 4	—

Eligibility Criteria

Inclusion Criteria

Enrolled at University of Michigan general hepatology clinics or inpatient wards
Documented diagnosis of alcohol-associated cirrhosis or alcoholic hepatitis or alcohol-related liver disease of any stage
Drinking of any amount of alcohol within the 6 months prior to recruitment
No alcohol use treatment within the past 1 month
Access to a phone for purposes of follow-up

Exclusion Criteria

Active alcohol use treatment
Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation.
Is enrolled in the multidisciplinary alcohol-related liver disease clinic at Michigan Medicine

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04473482). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.